320 related articles for article (PubMed ID: 32326227)
1. Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases.
Schepici G; Silvestro S; Trubiani O; Bramanti P; Mazzon E
Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32326227
[TBL] [Abstract][Full Text] [Related]
2. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease.
Pawlik P; Błochowiak K
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671562
[TBL] [Abstract][Full Text] [Related]
3. The potential roles of salivary biomarkers in neurodegenerative diseases.
Jiao LL; Dong HL; Liu MM; Wu PL; Cao Y; Zhang Y; Gao FG; Zhu HY
Neurobiol Dis; 2024 Apr; 193():106442. PubMed ID: 38382884
[TBL] [Abstract][Full Text] [Related]
4. Salivary biomarkers for the diagnosis and monitoring of neurological diseases.
Farah R; Haraty H; Salame Z; Fares Y; Ojcius DM; Said Sadier N
Biomed J; 2018 Apr; 41(2):63-87. PubMed ID: 29866603
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease.
Raghunathan R; Turajane K; Wong LC
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012563
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson.
Wolgin M; Zobernig M; Dvornyk V; Braun RJ; Kielbassa AM
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885007
[TBL] [Abstract][Full Text] [Related]
8. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis.
Carlomagno C; Banfi PI; Gualerzi A; Picciolini S; Volpato E; Meloni M; Lax A; Colombo E; Ticozzi N; Verde F; Silani V; Bedoni M
Sci Rep; 2020 Jun; 10(1):10175. PubMed ID: 32576912
[TBL] [Abstract][Full Text] [Related]
9. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
11. Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review.
Alqarni S; Alsebai M
Front Endocrinol (Lausanne); 2022; 13():1032192. PubMed ID: 36619561
[TBL] [Abstract][Full Text] [Related]
12. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
14. Salivary Biomarkers for Alzheimer's Disease and Related Disorders.
Ashton NJ; Ide M; Zetterberg H; Blennow K
Neurol Ther; 2019 Dec; 8(Suppl 2):83-94. PubMed ID: 31833026
[TBL] [Abstract][Full Text] [Related]
15. Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection.
Goldoni R; Dolci C; Boccalari E; Inchingolo F; Paghi A; Strambini L; Galimberti D; Tartaglia GM
Ageing Res Rev; 2022 Apr; 76():101587. PubMed ID: 35151849
[TBL] [Abstract][Full Text] [Related]
16. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnostics of neurodegenerative disorders.
Agrawal M; Biswas A
Front Mol Biosci; 2015; 2():54. PubMed ID: 26442283
[TBL] [Abstract][Full Text] [Related]
18. Salivary Redox Biomarkers in Selected Neurodegenerative Diseases.
Maciejczyk M; Zalewska A; Gerreth AK
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32059422
[TBL] [Abstract][Full Text] [Related]
19. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
[TBL] [Abstract][Full Text] [Related]
20. A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
Kruse N; Schlossmacher MG; Schulz-Schaeffer WJ; Vanmechelen E; Vanderstichele H; El-Agnaf OM; Mollenhauer B
PLoS One; 2016; 11(4):e0153564. PubMed ID: 27116005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
